214 fundamentals
An in-depth look to ANEBULO PHARMAC. DL-,001 operating, investing, and financing activities
214 free cash flow for Q1 25 is -1.52 M EUR. For 2024, 214 free cash flow was -7.55 M EUR and operating cash flow was -7.55 M EUR.
Q4 '20
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '20
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM